| scholarly article | Q13442814 |
| P356 | DOI | 10.1111/J.1365-2125.1978.TB01629.X |
| P953 | full work available at URL | https://europepmc.org/articles/PMC1429261 |
| https://europepmc.org/articles/PMC1429261?pdf=render | ||
| P932 | PMC publication ID | 1429261 |
| P698 | PubMed publication ID | 656267 |
| P5875 | ResearchGate publication ID | 22486574 |
| P2093 | author name string | P. Braun | |
| I. Turkalj | |||
| R. W. Griffith | |||
| P2860 | cites work | Environmental teratogens of man. | Q40495640 |
| Induction of ovulation with clompiphene citrate | Q44077193 | ||
| Cervical incompetence and premature delivery after bromocriptine therapy for infertility | Q44255700 | ||
| Outcome of pregnancy after induced ovulation. Follow-up of pregnancies and children born after gonadotropin therapy | Q45083719 | ||
| Bromocriptine treatment of female infertility: report of 13 pregnancies | Q67352733 | ||
| Management of hyperprolactinaemic amenorrhoea | Q67583331 | ||
| Outcome of pregnancy after clomiphene therapy | Q67829310 | ||
| Use of human menopausal gonadotropin for the induction of ovulation | Q68538504 | ||
| Pergonal (Menotropins): A Summary of Clinical Experience in the Induction of Ovulation and Pregnancy | Q71599460 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 227-231 | |
| P577 | publication date | 1978-03-01 | |
| P1433 | published in | British Journal of Clinical Pharmacology | Q176044 |
| P1476 | title | Outcome of pregnancy in mothers given bromocriptine | |
| P478 | volume | 5 |
| Q70437250 | A rational approach to ovulation induction |
| Q39566389 | AFP and hCG as tumor markers in therapy of malignant germ cell tumors |
| Q40305457 | Adverse effects of antiparkinsonian drugs |
| Q39799061 | Bromocriptine in the Treatment of Hypogonadism and Male Impotence |
| Q66701518 | Bromocriptine, pituitary tumours, and pregnancy |
| Q71158287 | Clinical course and outcome of thirty-five pregnancies in infertile hyperprolactinemic women |
| Q69880806 | Diagnosis and management of prolactinomas |
| Q95794039 | HCG in patients with hydatidiform mole or chorionepithelioma |
| Q44510933 | High-dose melphalan and cyclophosphamide pre-treatment |
| Q36660118 | Hyperprolactinaemia--investigation and results of treatment |
| Q95793927 | Hyperprolactinemia and sterility |
| Q44894345 | Intrauterine development, feto-placental function and pregnancy outcome after induction of ovulation with bromoergocryptine |
| Q40623716 | Investigation and Management of Symptomatic Hyperprolactinaemia |
| Q40300262 | Multiple pregnancies following induction of ovulation. |
| Q54317935 | Ovarian and placental hormones during prolactin suppression and stimulation in early human pregnancy. |
| Q33287330 | Parity, pregnancy and neonatal outcomes in women treated for hyperprolactinaemia compared with a control group |
| Q37976817 | Pharmacology of Bromocriptine in Health and Disease |
| Q40193543 | Pituitary microadenomas: diagnostic and therapeutic trends. |
| Q40303027 | Pituitary surgery for endocrine disorders |
| Q34517568 | Pituitary tumours during pregnancy in mothers treated with bromocriptine |
| Q66955324 | Pregnancies in women with hyperprolactinaemia: clinical course and obstetric complications of 41 pregnancies in 27 women |
| Q70353965 | Pregnancy in hyperprolactinemic women |
| Q66979379 | Pregnancy in patients presenting with hyperprolactinaemia |
| Q42359810 | Prolactinoma: a question of rational treatment |
| Q70576304 | Teratogenicity of bromocryptine in pregnant rats |
| Q93537895 | The role of prolactin in luteal inadequacy: treatment of hyperprolactinaemia with bromocriptine |
| Q40283167 | The use of bromocriptine in obstetrics and gynecology. |
| Q70576300 | The use of bromocriptine in the management of non-puerperal mastitis |
| Q71353674 | Trends in the management of prolactinomas |
| Q39799055 | Use of Bromocriptine in Hyperprolactinaemic Anovulation and Related Disorders |
Search more.